没有对脱敏反应的alectinib诱导的皮疹:一个病例报告和文献综述
Robin Raquel Rodriguez1, Jessie Dindak2, Janet Kline2
1Department of Medical Oncology, Allegheny Health Network, Pittsburgh, PA, USA. robinraquel@yahoo.com.
BMC pulmonary medicine
|July 15, 2023
概括
一名为非小细胞肺癌 (NSCLC) 治疗alectinib的患者发生了一种罕见的严重皮疹. 脱敏试验没有成功,突出了管理向治疗副作用的挑战.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
背景情况:
- 向疗法为具有特定突变的非小细胞肺癌 (NSCLC) 患者提供了新的希望.
- 对于提供者来说,了解和管理这些新型治疗方法的副作用,如阿列克提尼布,至关重要.
- 阿列克提尼布是ALK突变NSCLC的第二代氨酸激酶抑制剂.
研究的目的:
- 报告阿莱克提尼布在NSCLC患者中的罕见副作用.
- 审查有关alectinib诱导的副作用及其管理的文献.
- 增强提供者对与向肺癌治疗相关的潜在不良事件的理解.
主要方法:
- 一个63岁的女性患有IIIA期ALK阳性NSCLC的病例报告.
- 启动alectinib治疗和监测不良事件.
- 严重的黄斑皮疹,住院和随后的脱敏尝试的记录.
主要成果:
- 患者在阿列克提尼布治疗的第11天出现了严重的黄斑皮疹.
- 需要住院治疗皮疹管理.
- 在皮疹消失后对阿列克提尼布的脱敏化没有成功.
结论:
- 罕见的副作用,如严重的皮疹,可以发生在NSCLC的阿列克提尼布治疗.
- 这一案例凸显了管理alectinib诱导的不良事件所面临的挑战.
- 报告此类病例有助于制定未来的预防,治疗和重新挑战患者的目标治疗策略.
相关概念视频
Allergic Drug Reactions
895
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
895
Allergic Reactions
27.8K
Overview
27.8K
Desensitization and Tachyphylaxis
1.8K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.8K
Physical Properties of Amines
3.2K
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
3.2K
Antiasthma Drugs: Leukotriene Modifiers
368
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
368
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
204
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
204


